Bastion Asset Management’s NeoGenomics NEO Stock Holding History

Bastion Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-187,536	Closed	-$1.41M	–	74
2025 Q2	$1.41M	Buy	+187,536	New	+$1.51M	0.66%	46

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bastion Asset Management's NEO Position: Q3 2025 in Review

Bastion Asset Management sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 187,536 shares — an estimated $1.41M sold.

Bastion Asset Management first reported a position in NEO in Q2 2025 and held it in 1 quarter. The position peaked at $1.41M in Q2 2025. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

Bastion Asset Management reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
Bastion Asset Management sold 187,536 NeoGenomics shares in Q3 2025, an estimated $1.41M.
Bastion Asset Management first reported a position in NeoGenomics in Q2 2025 and held it in 1 quarter.
Bastion Asset Management's NeoGenomics position peaked at $1.41M in Q2 2025.
254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Bastion Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.